FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.21 | FHIR Version n/a User: [n/a]

4776411000001108: Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)
\UK product\Virtual medicinal product\Lidocaine 2% / Chlorhexidine 0.05% gel\Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)
\UK product\Virtual therapeutic moiety\Lidocaine + Chlorhexidine\Lidocaine 2% / Chlorhexidine 0.05% gel\Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)

\Medicinal product\Medicinal product categorized by disposition\Product containing sodium channel blocker (product)\Product containing lidocaine\Product containing chlorhexidine and lidocaine\Lidocaine + Chlorhexidine\Lidocaine 2% / Chlorhexidine 0.05% gel\Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing biguanide\Product containing chlorhexidine\Product containing chlorhexidine and lidocaine\Lidocaine + Chlorhexidine\Lidocaine 2% / Chlorhexidine 0.05% gel\Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing lidocaine\Product containing chlorhexidine and lidocaine\Lidocaine + Chlorhexidine\Lidocaine 2% / Chlorhexidine 0.05% gel\Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

18377501000001110 Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

54774101000001118 Lidocaine 2% and Chlorhexidine gel (AstraZeneca UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	Is a	Lidocaine 2% / Chlorhexidine 0.05% gel	true	Inferred relationship	Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	Has active ingredient	Lidocaine hydrochloride	false	Inferred relationship	Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	Has active ingredient	Chlorhexidine gluconate	false	Inferred relationship	Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	Has manufactured dose form	Gel	false	Inferred relationship	Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	Has specific active ingredient	Lidocaine hydrochloride	true	Inferred relationship	Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	Has specific active ingredient	Chlorhexidine gluconate	true	Inferred relationship	Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	Has active ingredient	Chlorhexidine	true	Inferred relationship	Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	Has active ingredient	Lidocaine	true	Inferred relationship	Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	Has dispensed dose form	Gel	true	Inferred relationship	Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	Has manufactured dose form	Gel	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml	Is pack of	False	Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	Inferred relationship	Existential restriction modifier
Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) 15 ml	Has AMP	True	Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
18377501000001110	Lidocaine 2% / Chlorhexidine 0.05% gel (AstraZeneca) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
54774101000001118	Lidocaine 2% and Chlorhexidine gel (AstraZeneca UK Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module